mobile menu
Question 2: Using FPG to safely titrate long acting basal insulin? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 8: Nutrition any changes warranted, especially any supplementation with PUFAs? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
The ORIGIN-Trial: Conclusion (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 7: Long acting insulins firstline therapy: What are the risks? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 6: Screening for IGT? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 5: Targeting FPG vs postprandial glucose? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 4: Specific benefits of early insulinisation? (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 3: Long acting insulins firstline therapy versus other established options (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Question 1: Targets of glycemic control (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
The ORIGIN-Trial (Archive)
11-Jun-12
Standl, Prof. E. / Hanefeld, Prof. M.
Intensive Insulin Therapy: Why, When and How to use in Type 2 Diabetes (Archive)
17-Oct-07
Kunt, PD Dr. T.
Intensive Insulin Therapy: Why, When and How to use in Type 2 Diabetes (Archive)
17-Oct-07
Kunt, PD Dr. T.
Beyond Oral Therapy: Which Insulin to start with? (Archive)
17-Oct-07
Cefalu, Dr. W.
Beyond Oral Therapy: Which Insulin to start with? (Archive)
17-Oct-07
Home, Prof. P.
Beyond Oral Therapy: Which Insulin to start with? (Archive)
17-Oct-07
Wolffenbuttel, Prof. B.
Clinical Use of Insulin Analogues in Pregnancy (Archive)
12-Sep-06
Jovanovic, Dr. L.
Diabetes and Hypoclycaemia: Have Insulin Analogues Made a Difference (Archive)
12-Sep-06
Frier, Prof. B.
Postprandial Metabolic Effects: Clinical Implications (Archive)
12-Sep-06
Beisswenger, Dr. P. J.
Glycemic Variability and Intensive Insulin Therapy (Archive)
12-Sep-06
Hirsch, Dr. I. B.